Titre : Namibie

Namibie : Questions médicales fréquentes

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer le paludisme en Namibie ?

Le diagnostic repose sur des tests sanguins pour détecter le parasite du paludisme.
Paludisme Diagnostic médical
#2

Quels tests pour la tuberculose en Namibie ?

Les tests incluent la radiographie pulmonaire et le test cutané à la tuberculine.
Tuberculose Tests diagnostiques
#3

Comment identifier le VIH en Namibie ?

Le VIH est diagnostiqué par des tests sanguins spécifiques, comme le test ELISA.
VIH Diagnostic du VIH
#4

Quels sont les signes de la fièvre jaune ?

Les signes incluent fièvre, douleurs musculaires et jaunisse. Un test sanguin confirme.
Fièvre jaune Symptômes
#5

Comment diagnostiquer la bilharziose ?

Le diagnostic se fait par l'analyse des selles ou des urines pour détecter les œufs.
Bilharziose Diagnostic médical

Symptômes 5

#1

Quels sont les symptômes du paludisme ?

Fièvre, frissons, sueurs, maux de tête et douleurs musculaires sont fréquents.
Paludisme Symptômes
#2

Quels symptômes de la tuberculose ?

Toux persistante, perte de poids, sueurs nocturnes et fatigue sont des indicateurs.
Tuberculose Symptômes
#3

Quels signes du VIH ?

Les symptômes initiaux incluent fièvre, fatigue, et ganglions lymphatiques enflés.
VIH Symptômes
#4

Quels symptômes de la fièvre jaune ?

Fièvre, douleurs abdominales, et jaunisse sont des symptômes clés de la maladie.
Fièvre jaune Symptômes
#5

Quels symptômes de la bilharziose ?

Les symptômes incluent douleurs abdominales, diarrhée et sang dans les urines.
Bilharziose Symptômes

Prévention 5

#1

Comment prévenir le paludisme ?

Utiliser des moustiquaires, des répulsifs et prendre des médicaments préventifs.
Paludisme Prévention
#2

Quelles mesures pour prévenir la tuberculose ?

Vaccination BCG et dépistage régulier des personnes à risque sont essentiels.
Tuberculose Prévention
#3

Comment prévenir le VIH ?

Utiliser des préservatifs et se soumettre à des tests réguliers sont des mesures clés.
VIH Prévention
#4

Quelles précautions pour la fièvre jaune ?

La vaccination est la meilleure méthode de prévention contre la fièvre jaune.
Fièvre jaune Prévention
#5

Comment prévenir la bilharziose ?

Éviter les eaux contaminées et traiter les zones d'eau stagnante sont recommandés.
Bilharziose Prévention

Traitements 5

#1

Quel traitement pour le paludisme ?

Le traitement standard inclut des médicaments antipaludiques comme l'artémisinine.
Paludisme Traitement
#2

Comment traiter la tuberculose ?

Le traitement repose sur une combinaison d'antibiotiques sur plusieurs mois.
Tuberculose Traitement
#3

Quel traitement pour le VIH ?

Le traitement antirétroviral (TAR) est essentiel pour gérer le VIH.
VIH Traitement antirétroviral
#4

Comment traiter la fièvre jaune ?

Il n'existe pas de traitement spécifique ; la prévention par vaccination est clé.
Fièvre jaune Prévention
#5

Quel traitement pour la bilharziose ?

Le traitement principal est le praziquantel, efficace contre les schistosomes.
Bilharziose Traitement

Complications 5

#1

Quelles complications du paludisme ?

Les complications incluent l'anémie sévère, le coma et la défaillance organique.
Paludisme Complications
#2

Quelles complications de la tuberculose ?

Les complications peuvent inclure la pneumonie et la propagation à d'autres organes.
Tuberculose Complications
#3

Quelles complications du VIH ?

Le VIH peut entraîner des infections opportunistes et des cancers associés.
VIH Complications
#4

Quelles complications de la fièvre jaune ?

Les complications graves incluent l'insuffisance hépatique et les hémorragies.
Fièvre jaune Complications
#5

Quelles complications de la bilharziose ?

Les complications peuvent inclure des lésions organiques et des problèmes urinaires.
Bilharziose Complications

Facteurs de risque 5

#1

Quels sont les facteurs de risque du paludisme ?

Les facteurs incluent vivre dans des zones endémiques et ne pas utiliser de moustiquaires.
Paludisme Facteurs de risque
#2

Quels facteurs de risque pour la tuberculose ?

Les facteurs incluent la malnutrition, le VIH et le surpeuplement.
Tuberculose Facteurs de risque
#3

Quels sont les facteurs de risque du VIH ?

Les comportements à risque, comme les rapports non protégés, augmentent le risque.
VIH Facteurs de risque
#4

Quels facteurs de risque pour la fièvre jaune ?

Voyager dans des zones endémiques sans vaccination augmente le risque d'infection.
Fièvre jaune Facteurs de risque
#5

Quels facteurs de risque pour la bilharziose ?

Le contact avec des eaux douces contaminées et la baignade dans ces eaux sont des risques.
Bilharziose Facteurs de risque
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Namibie : Questions médicales les plus fréquentes", "headline": "Namibie : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Namibie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-19", "dateModified": "2026-06-09", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Namibie" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Afrique australe", "url": "https://questionsmedicales.fr/mesh/D000353", "about": { "@type": "MedicalCondition", "name": "Afrique australe", "code": { "@type": "MedicalCode", "code": "D000353", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.058.290.175" } } }, "about": { "@type": "MedicalCondition", "name": "Namibie", "alternateName": "Namibia", "code": { "@type": "MedicalCode", "code": "D009276", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Siegfried Khaiseb", "url": "https://questionsmedicales.fr/author/Siegfried%20Khaiseb", "affiliation": { "@type": "Organization", "name": "Central Veterinary Laboratory (CVL), 24 Goethe Street, P. Bag 18137, Windhoek, Namibia." } }, { "@type": "Person", "name": "Umberto Molini", "url": "https://questionsmedicales.fr/author/Umberto%20Molini", "affiliation": { "@type": "Organization", "name": "Department of Pathobiology, School of Veterinary Medicine, Faculty of Agriculture and Natural Resources, University of Namibia, Neudamm Campus, Windhoek, Namibia." } }, { "@type": "Person", "name": "Giovanni Cattoli", "url": "https://questionsmedicales.fr/author/Giovanni%20Cattoli", "affiliation": { "@type": "Organization", "name": "Department of Nuclear Sciences and Applications, Animal Production and Health Laboratory, Joint FAO/IAEA Division of Nuclear Techniques in Food and Agriculture, International Atomic Energy Agency Laboratories, Friedenstrasse 1, A-2444, Seibersdorf, Austria." } }, { "@type": "Person", "name": "William G Dundon", "url": "https://questionsmedicales.fr/author/William%20G%20Dundon", "affiliation": { "@type": "Organization", "name": "Department of Nuclear Sciences and Applications, Animal Production and Health Laboratory, Joint FAO/IAEA Division of Nuclear Techniques in Food and Agriculture, International Atomic Energy Agency Laboratories, Friedenstrasse 1, A-2444, Seibersdorf, Austria. W.Dundon@iaea.org." } }, { "@type": "Person", "name": "Timothy Rennie", "url": "https://questionsmedicales.fr/author/Timothy%20Rennie", "affiliation": { "@type": "Organization", "name": "University of Namibia, School of Pharmacy, Private Bag, 13301, Windhoek, Namibia. Electronic address: trennie@unam.na." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Analysis of the Breast Cancer Journey in Namibia.", "datePublished": "2023-11-01", "url": "https://questionsmedicales.fr/article/37921764", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1001/jamanetworkopen.2023.41402" } }, { "@type": "ScholarlyArticle", "name": "Healthcare practitioners' experiences in managing HIV among young people in Namibia.", "datePublished": "2024-08-22", "url": "https://questionsmedicales.fr/article/39221712", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.4102/curationis.v47i2.2608" } }, { "@type": "ScholarlyArticle", "name": "High-resolution spatio-temporal risk mapping for malaria in Namibia: a comprehensive analysis.", "datePublished": "2024-10-05", "url": "https://questionsmedicales.fr/article/39367414", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12936-024-05103-w" } }, { "@type": "ScholarlyArticle", "name": "Electronic distance based clinical skills training development in family medicine in Namibia.", "datePublished": "2024-05-09", "url": "https://questionsmedicales.fr/article/38832379", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.4102/phcfm.v16i1.4352" } }, { "@type": "ScholarlyArticle", "name": "Experiences and challenges of enrolled nurses undertaking a Bachelor of Nursing Science programme in Namibia.", "datePublished": "2024-05-06", "url": "https://questionsmedicales.fr/article/38708759", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.4102/curationis.v47i1.2549" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Régions géographiques", "item": "https://questionsmedicales.fr/mesh/D005842" }, { "@type": "ListItem", "position": 3, "name": "Afrique", "item": "https://questionsmedicales.fr/mesh/D000349" }, { "@type": "ListItem", "position": 4, "name": "Afrique subsaharienne", "item": "https://questionsmedicales.fr/mesh/D017954" }, { "@type": "ListItem", "position": 5, "name": "Afrique australe", "item": "https://questionsmedicales.fr/mesh/D000353" }, { "@type": "ListItem", "position": 6, "name": "Namibie", "item": "https://questionsmedicales.fr/mesh/D009276" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Namibie - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Namibie", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2026-09-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Namibie", "description": "Comment diagnostiquer le paludisme en Namibie ?\nQuels tests pour la tuberculose en Namibie ?\nComment identifier le VIH en Namibie ?\nQuels sont les signes de la fièvre jaune ?\nComment diagnostiquer la bilharziose ?", "url": "https://questionsmedicales.fr/mesh/D009276#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Namibie", "description": "Quels sont les symptômes du paludisme ?\nQuels symptômes de la tuberculose ?\nQuels signes du VIH ?\nQuels symptômes de la fièvre jaune ?\nQuels symptômes de la bilharziose ?", "url": "https://questionsmedicales.fr/mesh/D009276#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Namibie", "description": "Comment prévenir le paludisme ?\nQuelles mesures pour prévenir la tuberculose ?\nComment prévenir le VIH ?\nQuelles précautions pour la fièvre jaune ?\nComment prévenir la bilharziose ?", "url": "https://questionsmedicales.fr/mesh/D009276#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Namibie", "description": "Quel traitement pour le paludisme ?\nComment traiter la tuberculose ?\nQuel traitement pour le VIH ?\nComment traiter la fièvre jaune ?\nQuel traitement pour la bilharziose ?", "url": "https://questionsmedicales.fr/mesh/D009276#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Namibie", "description": "Quelles complications du paludisme ?\nQuelles complications de la tuberculose ?\nQuelles complications du VIH ?\nQuelles complications de la fièvre jaune ?\nQuelles complications de la bilharziose ?", "url": "https://questionsmedicales.fr/mesh/D009276#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Namibie", "description": "Quels sont les facteurs de risque du paludisme ?\nQuels facteurs de risque pour la tuberculose ?\nQuels sont les facteurs de risque du VIH ?\nQuels facteurs de risque pour la fièvre jaune ?\nQuels facteurs de risque pour la bilharziose ?", "url": "https://questionsmedicales.fr/mesh/D009276#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer le paludisme en Namibie ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests sanguins pour détecter le parasite du paludisme." } }, { "@type": "Question", "name": "Quels tests pour la tuberculose en Namibie ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent la radiographie pulmonaire et le test cutané à la tuberculine." } }, { "@type": "Question", "name": "Comment identifier le VIH en Namibie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Le VIH est diagnostiqué par des tests sanguins spécifiques, comme le test ELISA." } }, { "@type": "Question", "name": "Quels sont les signes de la fièvre jaune ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent fièvre, douleurs musculaires et jaunisse. Un test sanguin confirme." } }, { "@type": "Question", "name": "Comment diagnostiquer la bilharziose ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par l'analyse des selles ou des urines pour détecter les œufs." } }, { "@type": "Question", "name": "Quels sont les symptômes du paludisme ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, frissons, sueurs, maux de tête et douleurs musculaires sont fréquents." } }, { "@type": "Question", "name": "Quels symptômes de la tuberculose ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Toux persistante, perte de poids, sueurs nocturnes et fatigue sont des indicateurs." } }, { "@type": "Question", "name": "Quels signes du VIH ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes initiaux incluent fièvre, fatigue, et ganglions lymphatiques enflés." } }, { "@type": "Question", "name": "Quels symptômes de la fièvre jaune ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, douleurs abdominales, et jaunisse sont des symptômes clés de la maladie." } }, { "@type": "Question", "name": "Quels symptômes de la bilharziose ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleurs abdominales, diarrhée et sang dans les urines." } }, { "@type": "Question", "name": "Comment prévenir le paludisme ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des moustiquaires, des répulsifs et prendre des médicaments préventifs." } }, { "@type": "Question", "name": "Quelles mesures pour prévenir la tuberculose ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Vaccination BCG et dépistage régulier des personnes à risque sont essentiels." } }, { "@type": "Question", "name": "Comment prévenir le VIH ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des préservatifs et se soumettre à des tests réguliers sont des mesures clés." } }, { "@type": "Question", "name": "Quelles précautions pour la fièvre jaune ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "La vaccination est la meilleure méthode de prévention contre la fièvre jaune." } }, { "@type": "Question", "name": "Comment prévenir la bilharziose ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les eaux contaminées et traiter les zones d'eau stagnante sont recommandés." } }, { "@type": "Question", "name": "Quel traitement pour le paludisme ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement standard inclut des médicaments antipaludiques comme l'artémisinine." } }, { "@type": "Question", "name": "Comment traiter la tuberculose ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement repose sur une combinaison d'antibiotiques sur plusieurs mois." } }, { "@type": "Question", "name": "Quel traitement pour le VIH ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement antirétroviral (TAR) est essentiel pour gérer le VIH." } }, { "@type": "Question", "name": "Comment traiter la fièvre jaune ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de traitement spécifique ; la prévention par vaccination est clé." } }, { "@type": "Question", "name": "Quel traitement pour la bilharziose ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement principal est le praziquantel, efficace contre les schistosomes." } }, { "@type": "Question", "name": "Quelles complications du paludisme ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'anémie sévère, le coma et la défaillance organique." } }, { "@type": "Question", "name": "Quelles complications de la tuberculose ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent inclure la pneumonie et la propagation à d'autres organes." } }, { "@type": "Question", "name": "Quelles complications du VIH ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Le VIH peut entraîner des infections opportunistes et des cancers associés." } }, { "@type": "Question", "name": "Quelles complications de la fièvre jaune ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications graves incluent l'insuffisance hépatique et les hémorragies." } }, { "@type": "Question", "name": "Quelles complications de la bilharziose ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent inclure des lésions organiques et des problèmes urinaires." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque du paludisme ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent vivre dans des zones endémiques et ne pas utiliser de moustiquaires." } }, { "@type": "Question", "name": "Quels facteurs de risque pour la tuberculose ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent la malnutrition, le VIH et le surpeuplement." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque du VIH ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Les comportements à risque, comme les rapports non protégés, augmentent le risque." } }, { "@type": "Question", "name": "Quels facteurs de risque pour la fièvre jaune ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Voyager dans des zones endémiques sans vaccination augmente le risque d'infection." } }, { "@type": "Question", "name": "Quels facteurs de risque pour la bilharziose ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Le contact avec des eaux douces contaminées et la baignade dans ces eaux sont des risques." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 09/06/2026

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Siegfried Khaiseb

14 publications dans cette catégorie

Affiliations :
  • Central Veterinary Laboratory (CVL), 24 Goethe Street, P. Bag 18137, Windhoek, Namibia.

Umberto Molini

11 publications dans cette catégorie

Affiliations :
  • Department of Pathobiology, School of Veterinary Medicine, Faculty of Agriculture and Natural Resources, University of Namibia, Neudamm Campus, Windhoek, Namibia.
  • Central Veterinary Laboratory (CVL), 24 Goethe Street, P. Bag 18137, Windhoek, Namibia.

Giovanni Cattoli

5 publications dans cette catégorie

Affiliations :
  • Department of Nuclear Sciences and Applications, Animal Production and Health Laboratory, Joint FAO/IAEA Division of Nuclear Techniques in Food and Agriculture, International Atomic Energy Agency Laboratories, Friedenstrasse 1, A-2444, Seibersdorf, Austria.

William G Dundon

4 publications dans cette catégorie

Affiliations :
  • Department of Nuclear Sciences and Applications, Animal Production and Health Laboratory, Joint FAO/IAEA Division of Nuclear Techniques in Food and Agriculture, International Atomic Energy Agency Laboratories, Friedenstrasse 1, A-2444, Seibersdorf, Austria. W.Dundon@iaea.org.

Timothy Rennie

4 publications dans cette catégorie

Affiliations :
  • University of Namibia, School of Pharmacy, Private Bag, 13301, Windhoek, Namibia. Electronic address: trennie@unam.na.
Publications dans "Namibie" :

Alaster Samkange

4 publications dans cette catégorie

Affiliations :
  • School of Veterinary Medicine, Faculty of Agriculture and Natural Resources, University of Namibia, P. Bag 13301, Pionierspark, Windhoek, Namibia.
Publications dans "Namibie" :

Juliet Kabajani

4 publications dans cette catégorie

Giovanni Franzo

4 publications dans cette catégorie

Affiliations :
  • Department of Animal Medicine, Production, and Health, University of Padova, Padova, Italy.
Publications dans "Namibie" :

Dan Kibuule

4 publications dans cette catégorie

Affiliations :
  • School of Pharmacy, Faculty of Health Sciences, University of Namibia, Windhoek Namibia.

Leigh Ann Miller

3 publications dans cette catégorie

Affiliations :
  • US Centers for Disease Control and Prevention, Windhoek, Namibia.

Penehafo Angula

3 publications dans cette catégorie

Affiliations :
  • School of Public Health, University of Namibia, Windhoek, Namibia.

Borden Mushonga

3 publications dans cette catégorie

Affiliations :
  • School of Veterinary Medicine, Faculty of Agriculture and Natural Resources, University of Namibia, P. Bag 13301, Pionierspark, Windhoek, Namibia.

Lauren M Coetzee

3 publications dans cette catégorie

Affiliations :
  • Central Veterinary Laboratory (CVL), Windhoek, Namibia.
Publications dans "Namibie" :

Mitchel Chatukuta

3 publications dans cette catégorie

Affiliations :
  • Research Department of Epidemiology and Public Health, University College London (UCL), London, UK.

Nora Groce

3 publications dans cette catégorie

Affiliations :
  • Research Department of Epidemiology and Public Health, University College London (UCL), London, UK.

Maria Kett

3 publications dans cette catégorie

Affiliations :
  • Research Department of Epidemiology and Public Health, University College London (UCL), London, UK.

Bernard Chiwome

3 publications dans cette catégorie

Affiliations :
  • Faculty of Agriculture and Natural Resources, School of Veterinary Medicine, University of Namibia, Neudamm Campus, Windhoek, Namibia.

Nestor Tomas

3 publications dans cette catégorie

Affiliations :
  • Department of General Nursing Science, Faculty of Health Science and Veterinary Medicine, University of Namibia, Rundu, Namibia.

Albertina Shilongo

3 publications dans cette catégorie

Affiliations :
  • Chief Veterinary Officer, Directorate of Veterinary Services, Ministry of Agriculture, Water and Land Reform, Windhoek, Namibia.

Jolandie van der Westhuizen

3 publications dans cette catégorie

Affiliations :
  • Central Veterinary Laboratory, Directorate of Veterinary Services (DVS), Ministry of Agriculture Water and Land Reform, Windhoek, Namibia.

Sources (59 au total)

Analysis of the Breast Cancer Journey in Namibia.

Breast cancer (BC) is the leading cancer among women in Namibia. Examining the BC journey in this multiracial country where inequalities remain large is needed to inform effective interventions to red... To describe the entire BC journey of Namibian women by race, utilizing the World Health Organization Global Breast Cancer Initiative (GBCI) framework.... This cohort study used the Namibian subset of the African Breast Cancer-Disparities in Outcomes prospective cohort. Participants were all Namibian residents with confirmed incident BC who presented at... Participants' self-reported ethnicities were aggregated into 3 population groups: Black, mixed ancestry, and White.... Three-year overall survival (OS) was examined using Cox models, and summary statistics were used to describe women's BC journey, including GBCI pillar key performance indicators: (1) early stage (TNM ... Of 405 women, there were 300 (74%) Black (mean [SD] age, 53 [15] years), 49 (12%) mixed ancestry (mean [SD] age, 53 [7] years), and 56 (14%) White (mean [SD] age, 59 [12] years) patients. Three-year O... In this cohort study of 405 Namibian residents with BC, marked racial disparities in survival were paralleled by inequities all along the BC journey. To improve BC survival, interventions are needed t...

Healthcare practitioners' experiences in managing HIV among young people in Namibia.

Low viral load suppression rates among older adolescents and young adults with HIV are a global challenge, including in Namibia. Healthcare providers struggle with managing these age groups due to the... This study aimed to explore and describe healthcare practitioners' understanding and experiences in managing older adolescents and younger adults living with HIV in seven high-burden districts of Nami... Qualitative descriptive phenomenological research was followed in this study. Healthcare practitioners directly managing older adolescents and younger adults living with HIV were purposively recruited... Two themes emerged from the study: (1) healthcare practitioners' knowledge of viral load management and (2) the strategies employed to manage high viral load in these age groups. These strategies incl... The findings revealed inadequate knowledge among healthcare practitioners regarding viral load management, which negatively impacts the provision of quality care and an effective HIV response within t...

High-resolution spatio-temporal risk mapping for malaria in Namibia: a comprehensive analysis.

Namibia, a low malaria transmission country targeting elimination, has made substantial progress in reducing malaria burden through improved case management, widespread indoor residual spraying and di... This study introduces innovative infectious disease mapping techniques to generate high-resolution spatio-temporal risk maps for malaria in Namibia. A two-stage approach is employed to create maps usi... A fine-scale spatial endemicity surface was produced for annual average incidence, followed by a spatio-temporal modelling of seasonal fluctuations in weekly incidence and aggregated further to distri... While the study acknowledges certain limitations, such as population mobility and incomplete clinical case reporting, it underscores the importance of continuously refining geostatistical techniques t...

Experiences and challenges of enrolled nurses undertaking a Bachelor of Nursing Science programme in Namibia.

Globally, enrolled nurses (ENs) are embarking on an educational journey to become registered nurses (RNs) in order to enhance their knowledge and career opportunities. However, their aspiration is not... This study aims to explore and describe the experiences and challenges of ENs undertaking a Bachelor of Nursing Science at the University of Namibia.... A qualitative, exploratory, descriptive and contextual research strategy was followed as the basis of conducting the study. A sample of 15 nursing students was purposively selected from the target pop... Three main themes subsequently emerged from the study: ENs' positive experiences advancing in the Bachelor of Nursing Science (BNSc) programme; nurses' negative experiences advancing in the BNSc progr...

Experiences of support by unsuppressed adolescents living with HIV and their caregivers in Windhoek, Namibia: a qualitative study.

Adolescents living with HIV (ALHIV) lag behind younger children and adults in the achievement of HIV care and treatment targets for HIV epidemic control. Treatment outcomes for adolescents may be infl... A qualitative descriptive and exploratory study was conducted in 13 public primary healthcare facilities in Windhoek, Namibia. A total of 25 in-depth interviews were conducted with unsuppressed adoles... Three main support domains for the unsuppressed adolescents emerged from our analysis, namely: psychosocial, clinical and care, and socioeconomic support. The psychosocial support was delivered throug... Psychosocial, clinical and care, and socioeconomic support are key elements in addressing the needs of adolescents challenged with achieving viral suppression. Health systems may benefit from whole-of...

Childbirth-choice facilitation experiences among women in selected public healthcare facilities in Namibia.

To describe childbirth-choice facilitation through the experiences of women, and explore women's views on their experiences of childbirth-choice facilitation.... This qualitative exploratory study included 12 women who gave birth in selected public hospitals in different parts of Namibia during the study period. Purposive sampling was adopted to ensure that pa... Women's choices on type of childbirth were assumed as they did not receive full information pertaining to different modes. The research findings were grouped into two main themes and five sub-themes, ... Women who gave birth in public hospitals reported a lack of choice regarding type of childbirth and a lack of shared decision-making. They would have preferred to receive balanced information about ty... Health professionals need to provide information on types of childbirth to women early in antenatal care so that they understand the choices and can give informed consent regarding their chosen mode w...

Utilisation of standardised outcomes measures by clinical Physiotherapists working in Namibia: a nationwide cross-sectional study.

The utilisation of standardised outcome measures (SOMs) is crucial for evaluating patients' health status. Physiotherapists are highly recommended to use SOMs routinely. Despite the well-documented be... A cross-sectional, nationwide, online survey was conducted and all registered qualified physiotherapists and intern physiotherapists working in public or private hospitals/clinics were invited to part... Of 230 participants who received the invitational link, 99 (43.0%) responded timeously to the call to participate. Although 97.9% (n=94) of the participants indicated having used at least one type of ... The rates for routine utilisation of SOMs by Namibian physiotherapists are unfavourable. Female gender and clinical specialty influenced the utilisation of SOMs in daily clinical practice. Cognisant o...

Enhanced active case finding of drug-resistant tuberculosis in Namibia: a protocol for the hotspots, hospitals, and households (H3TB) study.

Namibia is a high tuberculosis (TB)-burden country with an estimated incidence of 460/100 000 (around 12 000 cases) per year. Approximately 4.5% of new cases and 7.9% of previously treated TB cases ar... H3TB is an observational cross-sectional study evaluating MDR-TB active case finding strategies. Sputum samples from MDR-TB cases in three regions of Namibia will be evaluated by whole genome sequenci... Ethics approval was obtained. Participants will give informed consent. H3TB will capitalise on a partnership with the Ministry of Health and Social Services to follow up individuals diagnosed with MDR...

Determination of birth prevalence of sickle cell disease using point of care test HemotypeSC™ at Rundu Hospital, Namibia.

Sickle cell disease (SCD), a noncommunicable disease, has the greatest burden in sub-Saharan Africa. The majority of children (50-90%) with SCD die before their 5th birthday, with approximately 150,00... A cross-sectional descriptive study was carried out at Rundu Intermediate Hospital in the Kavango East Region. Two hundred and two (202) well newborns within 72 h of birth were recruited for the study... The majority of the participants (n = 105, 52%) were females, and (n = 97,48%) were males. The median age of the participants was 23 h (Q1, Q3; 11; 33),) with an age range of 2-98 h. Sickle cell trait... This study is the first to measure HbS gene carriage at birth using HemotypeSC point-of-care testing in Namibia. There was a moderate prevalence of sickle cell traits but no SCD. This baseline study m...